Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2014

Feb 28, 2014

30718_dirs_2014-02-28_2436218c-d55f-402a-8e74-d9f8aee02655.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2014-02-27

Reporting Person: STEER RANDOLPH C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-27 Common Stock M 5000 $61.46 Acquired 6000 Direct
2014-02-27 Common Stock S 5000 $88.78 Disposed 1000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-27 Stock Option $61.46 M 5000 Disposed 2020-10-27 Common Stock (5000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $87.39 2023-10-30 Common Stock (4000) 4000 Direct
Stock Option $66.9 2022-10-24 Common Stock (5000) 5000 Direct
Stock Option $70.35 2021-10-26 Common Stock (5000) 5000 Direct